A new paper, Assessing Value, Budget Impact, and Affordability in Asia, has been published in the International Journal of Technology Assessment in Health Care. This paper summarises the authors’ views on key thoughts and suggestions emerging from the 2016 HTAi Asia Policy Forum (HAPF) meeting.
The HTAi Annual Meeting 2017 will be held in Rome, Italy, 17-21st June 2017. The theme of the meeting is Towards an HTA Ecosystem: From Local Needs to Global Opportunities. Several members of the OHE team will attend and participate in the conference.
The fourth annual meeting of the HTAi Asia Policy Forum was held in November 2016. OHE produced Background Briefing Papers for each of these four meetings covering a variety of topics relevant to the development of HTA in Asia, all of which are now available. This post contains a summary of each report.
This paper uses MCDA to obtain preferences on decision criteria across three stakeholder groups (patients, clinicians and payers) in Italy and then uses these preferences to assess the value of obinutuzumab for rituximab-refractory iNHL.